Chen Chen
Stock Analyst at UBS
(4.54)
# 958
Out of 4,592 analysts
41
Total ratings
65.4%
Success rate
41.9%
Average return
Main Sectors:
Stocks Rated by Chen Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $185.50 → $160.80 | $93.95 | +71.15% | 6 | Jul 22, 2026 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Hold | $34.70 | $18.26 | +90.03% | 4 | Mar 13, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Maintained: Buy | $23.60 | $13.64 | +73.02% | 5 | Dec 14, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Hold | $63.80 | $81.75 | -21.96% | 6 | Dec 9, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $41.20 → $46.90 | $38.74 | +21.06% | 3 | Sep 3, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $50.00 → $56.30 | $37.72 | +49.26% | 4 | Sep 1, 2025 | |
| HKG: 6127 Joinn Laboratories(China)Co.,Ltd. | Maintained: Hold | $14.30 → $16.30 | $22.18 | n/a | 5 | Jul 14, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Upgraded: Buy | $40.10 → $70.40 | $160.70 | n/a | 2 | Nov 1, 2024 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Maintained: Buy | $20.00 → $9.50 | $20.82 | n/a | 2 | Sep 11, 2024 | |
| HKG: 0013 HUTCHMED (China) Limited | Initiated Coverage: Buy | $35.70 | $17.71 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $286 | $316.01 | n/a | 1 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $123.10 | $483.80 | n/a | 1 | Nov 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 220p | 839p | n/a | 1 | Aug 30, 2021 |
Akeso, Inc.
Jul 22, 2026
Maintained: Buy
Price Target: $185.50 → $160.80
Current: $93.95
Upside: +71.15%
Shanghai Junshi Biosciences Co., Ltd.
Mar 13, 2026
Maintained: Hold
Price Target: $34.70
Current: $18.26
Upside: +90.03%
InnoCare Pharma Limited
Dec 14, 2025
Maintained: Buy
Price Target: $23.60
Current: $13.64
Upside: +73.02%
RemeGen Co., Ltd.
Dec 9, 2025
Maintained: Hold
Price Target: $63.80
Current: $81.75
Upside: -21.96%
WuXi Biologics (Cayman) Inc.
Sep 3, 2025
Maintained: Buy
Price Target: $41.20 → $46.90
Current: $38.74
Upside: +21.06%
Hangzhou Tigermed Consulting Co., Ltd
Sep 1, 2025
Maintained: Buy
Price Target: $50.00 → $56.30
Current: $37.72
Upside: +49.26%
Joinn Laboratories(China)Co.,Ltd.
Jul 14, 2025
Maintained: Hold
Price Target: $14.30 → $16.30
Current: $22.18
Upside: n/a
WuXi AppTec Co., Ltd.
Nov 1, 2024
Upgraded: Buy
Price Target: $40.10 → $70.40
Current: $160.70
Upside: n/a
Shanghai MicroPort MedBot (Group) Co., Ltd.
Sep 11, 2024
Maintained: Buy
Price Target: $20.00 → $9.50
Current: $20.82
Upside: n/a
HUTCHMED (China) Limited
Apr 23, 2024
Initiated Coverage: Buy
Price Target: $35.70
Current: $17.71
Upside: n/a
Feb 29, 2024
Maintained: Buy
Price Target: $286
Current: $316.01
Upside: n/a
Nov 23, 2023
Initiated Coverage: Buy
Price Target: $123.10
Current: $483.80
Upside: n/a
Aug 30, 2021
Maintained: Hold
Price Target: 220p
Current: 839p
Upside: n/a